A Nomination Committee is appointed each year by the largest shareholders in accordance with the instructions for the Nomination Committee adopted by the Annual General Meeting. The instruction applies until the Annual General Meeting decides otherwise. According to the instructions for the Nomination Committee, the Nomination Committee shall, prior to the Annual General Meeting or, where applicable, to the Extraordinary General Meeting, propose the following:
- proposals for members of the Board of Directors;
- proposal for Board fees;
- proposal for auditor;
- proposal for auditor’s fees;
- proposal for Chairman of the Annual General Meeting; and
- proposal for instructions/guidelines for the appointment of the Nomination Committee.
Nomination Committee 2026
The nomination committee of Gruvaktiebolaget Viscaria (“Viscaria”) ahead of the annual general meeting 2026 has been appointed in accordance with the adopted nomination committee instruction.
The nomination committee consists of:
- Thomas von Koch, TomEnterprise Public Capital AB
- Håkan Eriksson, JOHECO AB and Skandinavkonsult i Stockholm AB[1]
- Joachim Spetz, Swedbank Robur Fonder
- Jan Ståhlberg
The shareholders who have appointed members to the nomination committee together represent approximately 24.1 percent of the number of votes of all shares in Viscaria.
The annual general meeting of Viscaria will be held on 7 May 2026.
Shareholders who wish to submit proposals to the nomination committee ahead of the annual general meeting 2026 can do so by email to valberedning@viscaria.com. For proposals to be processed by the nomination committee, they should be received no later than 31 January 2026.
For further information, please contact:
Per Colleen, chair of the board of directors and convener of the nomination committee
Telephone: +46 70-603 45 64
Email: valberedning@viscaria.com
[1] JOHECO AB and Skandinavkonsult i Stockholm AB have notified Viscaria that they have entered into a written agreement to, through the coordinated exercise of voting rights, adopt a long-term common view on the management of Viscaria.